Skip to main content
. Author manuscript; available in PMC: 2025 Mar 1.
Published in final edited form as: Osteoarthritis Cartilage. 2023 Sep 19;32(3):329–337. doi: 10.1016/j.joca.2023.09.007

Table 4.

Youden Indices of biomarker sets for the diagnosis of OA.

Model Threshold based on optimal Youden’s index in training dataset Sensitivity in testing dataset using training dataset threshold
[95% CIs]
Specificity in testing dataset using training dataset threshold
[95% CIs]
BMI 0.82 0.52 (0.46,0.59) 0.60 (0.54,0.66)
BMI, age, sex 0.85 0.42 (0.36,0.49) 0.82 (0.77,0.87)
ACTG 0.8 0.71 (0.66,0.77) 0.62 (0.56,0.68)
ACTG + BMI 0.73 0.71 (0.65,0.77) 0.67 (0.61,0.73)
23 RF peptides 0.86 0.81 (0.75,0.86) 0.82 (0.77,0.87)
23 RF peptides + BMI 0.81 0.86 (0.81,0.9) 0.76 (0.7,0.81)
17 uncorrelated peptides 0.83 0.77 (0.72,0.83) 0.84 (0.8,0.89)
17 uncorrelated peptides + BMI 0.79 0.88 (0.83,0.92) 0.73 (0.68,0.79)
8 significant peptides 0.81 0.78 (0.73,0.84) 0.78 (0.72,0.83)
8 significant peptides + BMI 0.9 0.94 (0.91,0.97) 0.69 (0.63,0.75)

For the list of the peptides in each set see Table 2; see Table S3 for the beta estimates for the models of demographics, Table S4 for models of the 23 RF peptides +/− BMI, Table S5 for models of the 17 uncorrelated peptides +/− BMI, and Table S6 for models of the 8 significant peptides +/− BMI